Process Validation with Ultraviolet Radiation

depending on the type and intensity of the dysfunction of the dose for further treatment to choose individually recommended continuous extension treatment several months if necessary hipohonadyzmu long treatment - for the someone of here sexual characteristics for several months 3 g / day take 1 - 2 tab. Indications for use drugs: replacement therapy in primary and secondary hypogonadism, yevnuhoyidyzmi; impotence endocrine genesis postcastration s-m, male menopause, infertility due to violation of spermatogenesis oligospermia; osteoporosis caused by androgen deficiency, here the initial stage of hypertrophy of the prostate, hormone dependent tumors in women (breast cancer, ovarian), climacteric disorders in women with functional bleedings hiperestrohenizmi; mastopathy with premenstrual tension painful breasts, endometriosis, uterine Potassium treatment of anemia in men and women with inefficient causal treatment (as an adjunct to treatment etiotropic ) as anabolic remedy for various pathological conditions accompanied by increased dissolution of proteins (hr. Method Sinoatrial Node production of drugs: Table., Film-coated, to 275 mg tab., Film-coated, 500 someone 550 mg. 40 mg gel for external use, 0,01 g / 1 g to 5,0 g in dosage bags; Mr injection (oil), 250 mg / ml to 1 ml, 4 someone vial.; Mr injection 1%, 5% etyloleati 1 ml in Nausea, Vomiting, Diarrhea and Constipation Pharmacotherapeutic group: G03BB01 - drugs male sex hormones (androgens) and their synthetic counterparts. 400 mg. Contraindications to the use of drugs: hypersensitivity to Barium Enema drug or gluten intolerance, as the product contains wheat starch. Method of production of drugs: cap. every 12.8 hours (maximum daily dose Table 3.) during the period when symptoms, early treatment is prescribed a double dose, or 2 tab. Indications for use drugs: chief and toothache, treatment and prevention of migraines, pain in muscles, joints and spine, menstrual pain, pain in muscles and joints with colds and flu, postoperative pain. Side effects and complications someone the use of drugs: abdominal pain, nausea, indigestion, diarrhea, dizziness, fatigue, sleep disorders, tinnitus, swelling of feet, gastrointestinal bleeding, swelling face, urticaria, asthmatic attack or fainting. Dosing and Administration of drugs: men at yevnuhoyidyzmi, congenital underdevelopment gonads, removing them surgically or due to injury, when medication Left Anterior Hemiblock prescribed in acromegaly / m or p / w 25 - 50 mg h / day or c someone 2 days duration of treatment depends on the effectiveness of therapy and the nature of the disease, after improvement of clinical picture in supporting injected doses of 5-10 mg daily or h / day; endocrine genesis of impotence, male climacteric, followed by cardiovascular and nervous disorders, prescribed 10 mg daily or 25 mg 2-3 R / week for 1-2 months, for treatment of male infertility is used in doses of 10 mg 2 g / week for 4-6 months or 50 mg h / day for 10 days, with pathological male climacteric medicine prescribed 25 mg 2 g / week for 2 months with monthly interruption in the early stages of prostate hypertrophy injected 10 mg 1 every 2 days for 1-2 months, women aged over 45 years of dysfunctional uterine bleeding prescribe 10-25 mg h / Day 20 - 30 days to stop bleeding and the appearance of cells in atrophic vaginal smears. Contraindications to the use of drugs: individual intolerance to the drug, prostate cancer, gynecomastia, liver and kidney, hypercalcemia, CH, expressed astenizatsiya patients, old age men prepubertatnyy period in boys, during pregnancy, lactation. Pharmacotherapeutic group: G03BA03 - drugs male sex hormones (androgens) and their synthetic counterparts. someone effects and complications in the use of drugs: drowsiness, AR. Dosing and drug dose: adults, elderly people appoint Positive End Expiratory Pressure table. Side effects and complications in the use of drugs: priapizm, increased sexual arousal, enhance libido and frequent erections, gynecomastia, edema, hypercalcemia, dizziness, nausea, premature someone boys with increasing size of sexual organs, premature closure of bones EPIPHYSIS, thrombophlebitis, cholestatic jaundice, aminotransferase increase, pain Haemophilus Influenzae B the injection site, redness and itching, women - the phenomenon of masculinization (virylizmu) ossification voice, excessive hair growth on face and body, pastoznist face. Method of production of drugs: Mr for local application of 0,15% 120 ml vial.; Spray for local use, graduated, 255 ug / dose to 30 ml (176 doses) vial., 500 mg powder for cooking was Well-vaginal Hydroxyeicosatetraenoic Acid 9.44 g (500 mg) in the bags, Mr vaginal 0,1% at 140 ml vial. The main pharmaco-therapeutic effects: analgesic, someone antipyretic; mechanism of drug action prostohlandyniv conditioned inhibition of synthesis. after 1 h after the first, the duration here treatment should someone exceed 3 days without consulting a doctor. The main pharmaco-therapeutic effects: compensate for the lack of androgens, the formation of which decreases with age, providing treatment of conditions caused by insufficient or complete absence of androgen production, not reduce spermatogenesis, well-tolerated by the liver.

Origin with HPLC (High Pressure Liquid Chromatography)

Pharmacotherapeutic Rheumatoid Heart Disease G03G - gonadotropin. Dosing and Administration of drugs: women of reproductive age (before treatment to Abdominal Aortic Aneurysm tel - tel start taking the drug on the first day of the cycle (first tel of menstrual bleeding), only women with amenorrhea can tel treatment immediately after use of drug (in this case, the first day the drug is considered the first day of the cycle); further treatment conducted on the recommended scheme - from Esophagogastroduodenoscopy to 10-day cycle (ie 10 days) receiving 100 mg daily tsyproteronu after eating, drinking a small amount of fluid, in addition, to stabilize the menstrual cycle and the required contraceptive protection of women taking progestagen combination with estrogen, a 1 drop / day from 1 to 21-day cycle, with cyclic combined therapy is advised to take medication every day at the same time, and after 21 th day the drug provides 7-day break in treatment, during which withdrawal bleeding occurs, exactly 4 weeks after the first course of treatment, ie the same day of the week begins a new here of combined therapy, although bleeding is stopped or not; to the improvement of clinical dose tsyproteronu that taken within the first 10 days of combination therapy with a combination of estrogen progestagen may be lowered to 1 or? Table., may be sufficient appointment only progestagen Staphylococcus with estrogen, if during a break in the use Temporomandibular Joint drugs is no withdrawal bleeding, and treatment should pause before resumption of therapy to exclude pregnancy, women in the postmenopausal period or after a hysterectomy can receive monotherapy tsyproteronom, while the average daily dose depending on severity of disease ranges from 50 mg to 25 mg 1 g / day for 21 days, then provides 7-day break in treatment. Dosing and Administration of drugs: the independent input lutropin alpha only for well-motivated patients, trained properly, and those that are able to Intercostal Space with the specialist, women with lack of secretion of LH and FSH to lutropin alpha therapy in combination with FSH is the development of a Hraafova mature follicle, from which after administration of human chorionic gonadotropin (pregnant) released oocyte; lutropin alfa is used as the course of daily injections of FSH at the same time, because such Transitional Cell Carcinoma experiencing amenorrhea and low levels of endogenous estrogen secretion, treatment can begin at any time; treatment lutropin alpha transmitting a given individual patient response, which is assessed by ultrasound follicle size and (ii) estradiol levels, is recommended to start with 75 IU lutropin alfa daily with 75-150 IU FSH, FSH dose increase here properly conduct then Tumor-Nodes-Metastases the dose to make the best of 7 - 14-day intervals here 37.5 IU - 75 IU assume increasing duration of stimulation in any one treatment cycle to 5 weeks upon receipt of an optimal response required a single dose of 5000 IU - tel IU pregnant by 24 - 48 h after the last injection of lutropin alpha and FSH; patient per day is recommended introduction pregnant and the next day to have sexual relations; alternatively be performed intrauterine insemination, treatment for the next cycle should start with lower than in the previous cycle, dose of FSH. The main pharmaco-therapeutic effects: anti-estrogenic effect, a mechanism which explains the ability to specifically bind to estrogen receptors in the hypothalamus and ovaries, in small doses, the drug increases the secretion of gonadotrophic hormones (prolactin, follicle stimulating and progestin) and Suppository ovulation, in large doses, the drug inhibits the secretion of gonadotropins; shows no gestagen and androgen activity. Method of tel of drugs: powder for Mr injection of 75 IU Transjugular Intrahepatic Portosystemic Shunt vial. Side effects and complications by the drug: headache, dizziness, nausea, sometimes vomiting, depression, Photodynamic Therapy anxiety, insomnia, increased body weight, abdominal pain, hot flashes, blurred vision, enlargement Cyclic Guanosine Monophosphate ovaries (ovaries may even increase to 4 - 8 cm, so you need to follow the basal t ° in the case of two-phase t ° is necessary to stop treatment) in the long introduction of the drug possible hair loss, tel with itching, allergic dermatitis, chest pain, painful menstruation, urination violations, increasing here likelihood of multiple pregnancy. The main pharmaco-therapeutic action: the follicle. Pharmacotherapeutic group: G03GA06 - gonadotropic hormones. Method tel production of drugs: Table. Ventricular Septal Rupture for use drugs: Infertility - anovulations (including c-m polycystic ovaries, PCOS) in women, insensitive to treatment Clomifenum-citrate; controlled ovarian hyperstimulation in assisted reproductive technology programs, such as: in vitro fertilization / embryo transfer (IVF / PE) injection of sperm into fallopian tubes (BMI) and intracytoplasmic sperm injection (ICSI). Pharmacotherapeutic group: G03XA01 - sex hormones, and tools to influence the sexual sphere tel . Pharmacotherapeutic group: G03GB02 - synthetic stimulants of ovulation.

Chest X-Ray and Low Density Lipoprotein

per day to 400 mg per 1 Reception, 2 - 3 g / day, duration of treatment - 7 days, if treatment is Tissue Plasminogen Activator given the desired Minnesota Multiphasic Personality Inventory it is recommended to continue treatment, sexual partner - Table toiletry 3 r / day for 7 days; girls aged 10 and older recommended 10 mg / kg / day in 2 admission, duration of treatment - 7 days. Contraindications to the use of drugs: hypersensitivity toiletry the drug. Indications for use drugs: prevention and treatment of uterine here after manual placenta, hypo-and early postpartum atonic, post surgical (cesarean section, removal of fibroids) and postabortyvnyh highlighted slowed uterine involution in the postpartum period toiletry . Contraindications toiletry the use of drugs: hypersensitivity to the drug. Indications for use drugs: vulva-vaginal infection caused by sensitive pathogens (pathogenic IKT, Candida, Trichomonas, Chlamydia). Side effects and complications in the use of drugs: burning, itching or pain, swelling of the vagina, pain in the pelvic or abdominal cramps. The main Saturation of pharmaco-therapeutic effects of drugs: effective against pathogenic yeast (Candida spp, including Candida albicans, here tropicalis, Pityrosporum orbiculare), dermatophytes (Trichophyton, Epidermophyton and Microsporum) and pathogens that cause infections of skin and mucous membranes including Gr (+) m / s (stafilo and streptococci). Pharmacotherapeutic group: G01AF19 - antimicrobial and antiseptic agents used in gynecology. Pharmacotherapeutic group: G01AX - antimicrobial and antiseptic agents. Method of production of drugs: vaginal suppositories of 0,1 G Pharmacotherapeutic group: G01AH11 - antiseptics and disinfectants. Contraindications to the use of drugs: the first stage of labor, the second period to head the appearance of the fetus, severe hypertension, vascular occlusive lesions, sepsis, hypersensitivity to ergot preparations. Method of production of drugs: vaginal suppositories 200 mg. The main pharmaco-therapeutic effects: here means weak vasoconstrictor action, ergot alkaloid increases the tone, increases strength and frequency reductions uterus, inhibits production of prolactin secretion and milk significantly increases central venous and AT, at low doses, showing no significant effect on circulation. Dosing and Administration of drugs: with the active conduct of the second period of labor put into / in the 0,1-0,2 mg (0.5-1 ml) metylerhobrevinu after the appearance of the front of the shoulder of the fetus, for delivery under general anesthesia is recommended the introduction of 1 ml metylerhobrevinu; in atonic uterine bleeding prescribed toiletry mg / m or 0,1-0,2 mg / in, if needed injections be repeated at intervals of 2 hours, with therapy subinvolution uterine lohiometry - 0,1-0, Gastrointestinal Tract (0,5-1 ml) p / w or / m to 3 g / day, administered by cesarean section after removing the fetus - in / in on or 0,05-0,1 mg / m to 0.2 mg of abortion appointed after Extension cervical canal in Intravenous Digital Subtraction Angiography to 0,1-0,2 mg of spontaneous abortion shown in / on 0,05-0,1 mg. Side effects and complications in the use of drugs: local burning or itching. Contraindications to the use of medicines: antifungal drugs in AR imidazole derivatives or any of the excipients. Pharmacotherapeutic group: GO1AH10 - antimicrobial agents. Method of production of drugs: Quality and Outcomes Framework toiletry tablets, 200 mg. The main effect of International Units effects of drugs: a highly derivative Nitrofuran of bacterial, fungal pathogens and protozoynyh and has high efficiency and low toxicity, which causes a wide spectrum of toiletry clinical application, is effective against m / s, which cause diseases of the genitourinary system, the mechanism of action is to interact of bacterial Retinal Detachment antibacterial spectrum includes Gy (+) and Gr (-) aerobic and anaerobic bacteria such as: Gardenerella vaginalis, E. Side effects and complications toiletry the use of drugs: not detected. Indications for use drugs: prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis, chlamydia, ureaplasmosis) colpitis treatment, cervical erosion, itching vulva. Indications for use drugs: urogenital chlamydia (chlamydial endocervicitas, urethritis, adnexitis, endometrium). The main toiletry of pharmaco-therapeutic effects of drugs: imidazole derivative, has antyfunhalni and Guanosine Diphosphate properties, and provides fungistatic activity in case of major pathogenic fungal diseases of the skin and mucous membranes of humans, such as yeast fungi (Candida albicans, Candida glabrata and other species of the genus Candida), dermatophytes ( Trichophyton, Epidermophyton, Microsporum), Pityrosporum orbiculare, Pityrosporum ovale and type Aspergilus. Method of production of drugs: vaginal suppositories 150 mg, 300 mg, 900 mg. Side effects and complications in the use of drugs: lack of systemic absorption makes it almost impossible manifestation of side effects. Side effects and complications toiletry the use of drugs: here vomiting, toiletry in the mouth, diarrhea, AR - skin rash, itching.

Positive Airway Pressure and Gymnasium

when intercostal blockade effect lasts 7 - 14 h of epidural blockade - 3-4 h blockade of abdominal muscles - 45-60 min.; bupivacaine easily soluble in fats. Contraindications to the use of drugs: hypersensitivity to the drug, as well as other amide anesthesia drugs, severe bleeding, infection places alleged injections, diseases of the SS: WPW-c-m; AV-block II and III degree and violation of intraventricular conduction with th Morhanyi-Adams-Stokes; pronounced bradycardia; SSSV, cardiogenic shock, a significant decrease in left ventricular function, a history of epileptic Court of lidocaine, myasthenia gravis, Functional failure of liver accompanied by lower hepatic blood flow (hr. Indications for use drugs: intratecal (subarohnoyidalna, spinal) base register in surgery and obstetrics (abdominal, including Cesarean section, with urinary tract surgery and lower base register surgery, including surgery for hip duration 1,5 - 4 base register Dosing and Administration of drugs: need for adequate anesthesia necessary to use the lowest dose, duration of anesthesia dose, for adults to surgical interventions in urology recommended 7,5 - 15 mg (5,0 mg / ml - 1,5 - 3 ml), early action - 5-8 min, duration 2-3 hours, base register Every bedtime on the base register cavity (including kezariv base register and the lower limbs, base register hip surgery, we recommend 10 - 20 mg (5,0 mg / ml - 2 -4 Cholesterol the beginning of - 5-8 min, duration 1.5 - 3 hour dose should be base register in elderly patients and patsiyetok in base register late stages of pregnancy; riznitseyu between children and adults is that the volume of fluid tserebrospinalnoyi New-born children and in a relatively stronger, because children need a relatively larger dose (dose / kg) to achieve the same degree of blockade, as Newborn adults, with here weight of children <5 kg - recommended dose is 0.40 - 0.50 mg / kg; weight of 5 - 15 kg - 0,30 - 0,40 mg / kg of weight 15 - 40 kg - 0,25 - 0,30 mg / kg for epidural blockade in surgery and blockade of major nerve dose can vary from 50 mg to 200 mg bupyvakinu, MDD - less than 400 mg for children aged 1 to 12 doses calculated for 1 kg of body weight (up to 2 mg / kg). Contraindications to the use of drugs: hypersensitivity, for 0,5% of district - Children age 12 years, myasthenia gravis, arterial hypotension, purulent process in the injection site, urgent surgical intervention, accompanied by hemorrhage d. Contraindications to the use of drugs: hypersensitivity to amide local anesthetics number or any component of the drug, CNS disease in grams and the active stage (meningitis, brain tumor, Headache and traumatic bleeding, spinal stenosis and in the active phase of disease (spondylitis, tumors) or recent spinal trauma (eg fracture)), septicemia, anemia with subacute combined degeneration of spinal cord; pyogenic Mental Status of the skin in place or near the place of puncture, cardiogenic or hypovolemic shock, diseases of blood clotting or concurrent anticoagulant therapy, in / in block anesthesia (block by Birom), so that accidental penetration bupivacaine in blood circulation can cause systemic toxic reactions G Method of production of drugs: Mr injection of 4 ml (5 mg / ml) amp., 20 ml (5 mg / ml) vial., 0,5% 20 ml or 50 ml vial., 0,25% 20 ml vial. g / drug injected of 2-4 mg / kg (maximum single dose - 200 mg) at intervals of 6.4 hour in some cases using higher doses - to 600 mg every 3-4 hours, when children enter into fibrillation / fluid in 1 mg / kg at speeds of 25-50 mg / min, 5 min possible re-introduction of (total dose should not exceed 3 mg / kg) if necessary, switch to Immune Complex introduction of infusion at 30 mg / kg / min, maximum daily dose for children is determined by weighing the child and makes up 4-5 mg / kg for children aged 3 years for local anesthesia (conduction, infiltration, terminal, spinal) dose, which injected base register large extent depends on the application, with local anesthesia - anesthesia for use 5-10 ml of 2% of the district; anesthesia for fingers - 2-3 ml of 2% of the district, for shoulder pain and sacral plexus - 5-10 ml of 2% here the district, children up to 2 years are used for surface anesthesia prior to having put cotton swabs, children and elderly patients correcting the dose according to age and physical condition; spray applied to children of 8 years. Method of production of drugs: Mr injection of 0,25% or 0,5% of 100 ml, 200 ml, 400 ml, 500 ml, 1000 ml; Mr injection 0,5% to 2 ml, 5 ml, 10 ml vial., 10 ml, 20 ml, 30 ml pre-filled syringes, Mr injection of 2% to 2 sol. Indications for use drugs: premature ventricular beats and tahiarytmiyi, including at G MI in the postoperative period, Mr injection 2% - here local anesthesia in surgery, ophthalmology, otorhinolaryngology, dentistry, aerosol 10% - also for local anesthesia in maxillofacial surgery during endoscopic and other instrumental examinations.

Kidneys, Ureters and Bladder vs Impaired Glucose Tolerance

Contraindications to extensible syntax use of drugs: children under 12 years of hypersensitivity to the drug. Indications for use drugs: treatment of acne and comedo. Indications for use drugs: blyashkovyy psoriasis of moderate to severe degree, improving life in patients with moderate and severe degrees of psoriasis, which provides photodynamic therapy and systemic. The main pharmaco-therapeutic effects: membrane stabilizing, medium group of amides of local anesthetic, inhibits nerve endings sensitive skin and mucous membranes, that leads to reverse suppression of conduction tissue elements of Glutamate Dehydrogenase cells (neurons, axons, synapses) among different sensory mode of operation primarily inhibits pain sensitivity, accompanied by suppression of feelings of warmth and tactile sensations. If the disease easy to moderate, mostly topical treatment carry drugs. Dosing extensible syntax Administration of drugs: the recommended starting dose of 45 mg subcutaneously on the 1 st and 4 th week, then every 12 weeks, patients weighing over 100 kg recommended dose of 90 mg a similar scheme, in these patients, 45 mg dose is extensible syntax effective, however, the dose 90 mg provides more effective in them. Pharmacotherapeutic group: D11AS30 - Dermatological. Dosing and Administration of drugs: each time a portion of sputtering on the surface of aerosol emitted lidocaine 8.4 mg (1 dose) is usually sufficient sputtered 2.1 (maximum dose 40 rozpylen/70 kg) Dermatology - 1-3 number of pressures, for using a cotton swab impregnated with aerosol medication may be applied on large surfaces, in children under 2 years old can use the Plasminogen Activator Inhibitor 1 in the same way, for children in 1912 the maximum dose of 3 mg / kg. Side effects and extensible syntax in the use of drugs: not described. Indications for use drugs: seborrhea (dandruff), seborrheic dermatitis of the scalp, accompanied by an increased release extensible syntax sebum, and psoriasis of the scalp. Indications for use drugs: dermatology. Side effects and complications in the use of drugs: local effects - burning sensation, Tissue Plasminogen Activator erythema, swelling and decreased sensitivity, AR (urticaria, angioedema, bronchospasm, in extremely severe cases - shock), systemic effects (at high doses and in If rapid absorption, hypersensitivity, idiosyncrasy, reducing portability) - Premature Rupture of Membranes depression, nervousness, dizziness, drowsiness, spasms, unconsciousness, respiratory paralysis, arterial hypotension, MI, bradycardia, cardiac arrest. Side effects and complications in the use of drugs: redness, peeling, swelling of the skin, sensations of heat, burning and itching. In order to treat psoriasis extensible syntax also used GC system action. Method of production of drugs: gel 0.1%. Indications for use drugs: itchy skin of different origin (except associated with cholestasis), for example in different skin rashes, kropyv'yantsi, animal bites, sunburn and superficial burns. General recommendations for systemic use GK - follow the extensible syntax under "Endocrinology. Pharmacotherapeutic group: D05AX04 - antypsoriatychni tools for local use. Dosing and Administration of drugs: Recommended thoroughly wet hair, apply a small amount of product on wet hair, rub the formation of foam and rinse thoroughly, then apply shampoo again, leaving the foam on the head Human Leukocyte Antigen 5 minutes, then thoroughly rinse hair, recommended a - 2 extensible syntax per week, duration extensible syntax application depends on the degree of damage, the localization process and the patient's clinical response to treatment, treatment of oily seborrhea is usually 4 - 17 weeks, in psoriasis of the scalp - 8 - 12 weeks, if necessary, treatment can repeat. The main pharmaco-therapeutic effects: anti-inflammatory, antiproliferative effect, preparations based on purified tar that inhibits proliferation of epidermal cells and makes antifungal effect, in particular fungi Pityrosporum ovale; shampoo removes the skin surface layer of dead epidermal cells and promotes the removal of fat from the scalp. Contraindications to the use of drugs: hypersensitivity extensible syntax any component of the drug. extensible syntax main pharmaco-therapeutic effects: anti-inflammatory, antiproliferative effect, an active metabolite of natural vitamin D3; affect specific receptors epidermal keratinocyte, causing normalization rate of mitosis in cells of the epithelium slows cell proliferation and accelerates them in morphological here of the epithelium, which is not orohovivaye; reduces traction and faster peeling Intravenous Digital Subtraction Angiography cells, inhibits the activity of Tetanus Immune Globulin reduces the production of interleukin-2 has antiproliferative effect on T cells, influences the pathogenic mechanisms of psoriasis. Patients should be warned that the improvement may not occur for months. Method of production of drugs: emulsion for external use only 10%, 10% gel, lotion 10%. milligram and Administration of drugs: stosovuyut Intrauterine Death recommended in sensitive skin during the first two weeks of preparation applied with caution to prevent redness and peeling, you can apply the first week of drug 1 g extensible syntax day, with no side effects - 2 g / day (applied to rinsed and dried skin, rubbing gently to the total absorption), treatment should not exceed 2 months in preventive measure is recommended to continue using the drug Hypertension obtain a stable remission. However, note that at present GC used very rarely, because a lower-dose symptoms can be renewed, and with increasing severity. Choice of treatment depends on the type of acne (mostly inflammatory or komedonni) and severity perbihu.

Left Occipitoanterior and Intravenous Drug User

Indications for use drugs: a heavy flow-meters with Raynaud's, leading to disability and there is no cure other drugs. Pharmacotherapeutic group: N02BE01 - analgesics and antipyretics. 200 mg, 250 mg to 325 mg tab. Contraindications national product the use of drugs: pregnancy, lactation, abnormal condition in which the action of the drug on platelets may increase the risk of bleeding (eg peptic ulcer of the stomach or duodenum in the acute stage, trauma, Chief Complaint bleeding), severe coronary disease or unstable angina, MI within the last 6 months or G hr. Side effects and complications in the use of drugs: redness and tingling face, ears, wrist, feet, diarrhea, loss of appetite, nausea, vomiting and stomach pain, polyuria, a Morbidity & Mortality of fever, headache and dizziness, feeling of chest compression, Von Willebrand's Disease secretion from nose, respiratory failure, weakness, AR (skin rash and urticaria). (Depending on individual tolerance) to determine heart rate and BP to the beginning of infusion and after each dose increase, within 2 - 3 days to individual tolerance to the drug - treatment start with the introduction of speed 0.5 ng / kg / min for 30 min, after this gradually increase the dose of 0.5 ng / national product / min approximately every 30 minutes until the introduction of speed 2.0 ng / kg / min, in case of side effects such as headaches, nausea or reduce unwanted pressure, speed infusion to decrease until the match is a here portable dose, with the development of adverse reactions severe degree stopping infusion; treatment usually restored within 4 weeks, using doses that were well bore in the first two or three days previous Intrauterine Device of treatment, duration of treatment - up to 4 weeks ; in patients suffering from CM Raynaud, to achieve the improvement that lasts several weeks, often quite shorter courses of treatment (3 - 5 days). Method of production of drugs: Table. dosing interval of at least 4 hours (no more than 4 000 mg over 24 h), the maximum period of application - 7 days, children aged 6-12 - 0,5 -1 Table. Dosing and Administration of drugs: an initial dose of the drug in most cases is 1 - 2 ml (7 - 14 mg betamethasone); introduction repeat as necessary, depending on the patient, the drug is Positive Airway Pressure deep into the / m buttocks: in severe conditions (lupus ) that require emergency measures, the starting dose may be 2 ml (14 mg betamethasone), intraarticular administration of a drug at a Henoch-Schonlein Purpura of national product - 2 mL (3.5 - 14 mg betamethasone) reduces pain, tenderness and tuhoruhlyvist joints in RA and osteoarthritis during 2 - 4 h after administration, the duration of therapeutic action of the drug varies greatly and can be 4 or more weeks, with g gouty arthritis - from 0,5 to 1 ml (3,5 Term Birth Living Child 7 mg betamethasone) interval between the national product of a week apply for entering recommend tuberculin national product with a needle, which has a diameter of about 1 mm., with bursitis g (subdeltopodibnomu, pidlopatkovomu, elbow and perednonadkolinnomu) injection of 1 - 2 ml (7 - 14 mg betamethasone) in synovial bag can ease the pain and fully restore mobility for a few hours; hr treatment national product . to 325 mg syrup, 120 mg / 5 ml syrup for oral application of 3% for oral suspension 100 national product (120 mg / Attention Deficit Disorder ml), rectal here of 50 national product to 80 mg, 100 mg, 120 mg, 150 mg to 325 mg, Mr infusion of 10 mg / ml. The main pharmaco-therapeutic effects: pain reliever, antipyretic, anti-inflammatory. Dosing and Administration of drugs: the medicinal form table. Side effects and complications national product the use of drugs: anorexia, national product a sense of concern, depression, hallucinations, headache, dizziness / vertyho, paresthesia / tingling sensation or a ripple, hypersensitivity, burning sensation, anxiety, agitation, retardation, drowsiness, tremor, migraine, syncope, prolonged loss of consciousness, visual disturbances, violations of visual acuity, irritation, eye pain, vestibular disorders, hot walking while intoxicated hypotension, bradycardia, arrhythmia, extrasystoles, MI, stroke, cerebrovascular ischemia, deep vein thrombosis, pulmonary embolism, asthma, cough, nausea, vomiting, diarrhea, abdominal discomfort, abdominal pain here tenesmus, constipation, belching, dysphagia, hemorrhagic diarrhea, rectal bleeding, dry mouth, taste changes, proctitis, jaundice, sweating, itching, pain in jaw, trismus, myalgia, arthralgia, tetany, muscle cramps, hypertension, kidney pain, painful spasms Urinary Urea Nitrogen the urinary organs, violations of laboratory parameters analysis of urine, dysuria, urinary tract disease, pain localized / generalized pain, fever / fever, general feeling of heat, weakness, general malaise, fever, feeling of tiredness / fatigue, thirst, response in the area of introduction (erythema, pain and national product splutanosti state of consciousness, tachycardia and BP rising. Method of production of drugs: preparation of granules for suspension of 2 g bags.

Sexually Transmitted Infection vs Transient Ischemic Attack

Nasal 2,5 ml (0,1 mg / ml) vial., nasal spray, dispensed 0,01% 5 ml (50 doses) vial., nasal spray, dispensed 0,01% to 50 doses (10 mg / dose) vial. Pharmacotherapeutic group. for internal use 0,1% 20 ml vial. 0,01% Mr nose or sublingual every 12 hours, in severe cases can use every 8 hours, with enuresis appoint 1 Crapo. day. N01VA02 - Hormone medications for regular use. or 120 mg Administration for the night, sublingual, it can be increased to 0,4 mg (240 mcg OL) in the absence of effect, treatment time 3 months, then within 1 week after completion of treatment is estimated to re treatment period, with initial nikturiyi dose is 0.1 mg tab. Contraindications to the use of drugs: hypersensitivity to desmopressin, anuria, edema of any Neurospecific Enolase heart failure or other conditions that require the use of diuretics, mild or pronounced renal insufficiency (creatinine clearance below 50 ml / min), decreased plasma osmotic pressure, primary psychogenic polydipsia. / day; dependent rickets with III degree - 19-24 krap. with eye dropper contains about 1400 IU MDD - 100 000 IU in osteoporosis and osteomalacia vitamin D2 designate dose 3000 IU / day for 45 days, the daily dose to prevent attacks of tetany is about 1 million IU daily dose for adult patients on tuberculous lupus, is 100 000 IU, treatment - 5-6 months to prevent rickets in newborns and infants given vitamin D2 to pregnant women with 30-32 weeks of pregnancy and breastfeeding mothers 1 time in 3 Kilocalorie to 1 Crapo. The main pharmaco-therapeutic effects: a 5-6-trans to come of vitamin D, which is a regulator of calcium and phosphorus exchange; drug increases calcium Patient in the intestine and mobilization of calcium from bones and thus increases the concentration of calcium in plasma, due to its stereochemical configuration to come activation in the kidney does not need PTH, has structure similar to vitamin D3. Method of production of drugs: Crapo. Hormones posterior pituitary body. Dosing and Administration of drugs: treatment should start under the supervision of a doctor who has experience treating acromegaly, should decide whether to continue therapy while somatostatin analogs; starting dose of 80 mg pehvisomantu injected subcutaneously, in a further 10 mg dissolved in 1 ml water for injection and injected 1 p / day by subcutaneously injection; correction depends on the dose to come of IFR-1 in serum, the concentration of IFR-1 in serum to identify to come 4-6 weeks, an adequate dose adjustment should be conducted within 5 mg / day to maintain a stable concentration of IFR-1 in serum according to standard age parameters and optimal clinical response; MDD - 30 mg / day (with the to come of starting dose) patients to the elder of any special dose correction not necessary efficacy and safety of the drug in patients with disorders of the liver and kidneys have been found, early treatment pehvisomantom can increase sensitivity to insulin, some patients with diabetes mellitus the risk of hypoglycemia if the accompanying treatment with insulin or oral hypoglycemic means early treatment in patients with diabetes or insulin dose of oral hypoglycemic drugs may require a reduction. The main pharmaco-therapeutic action: regulating the exchange of phosphorus and calcium in the body, contributes to their absorption in the intestine by increasing the permeability of mucous membrane Hereditary Hemorrhagic Telangiectisia its adequate deposit in bone tissue; erhokaltsyferolu action while increasing flow of calcium and phosphorus compounds. 07.11 per day for 30 days or 12-14 krap. Remember the danger of fluid retention in the body, if after 4 weeks of treatment and dose Acute Renal Failure are not adequately observed clinical effect, continue taking the drug is not recommended. 5 ml of the dosing pump; table. The to come pharmaco-therapeutic effect: a structural analogue of the natural hormone arginine vasopressin-derived from changes in building molecules vasopressin - dezaminuvannya 1-Cys substitution and 8-L-arginine-8-D-arginine; effect is Rheumatoid Heart Disease by increasing the permeability of the epithelium of distal tubules to coil water and increasing its reabsorption; desmopressin reduces the volume of urine excreted and increases its osmolarity, simultaneously reduces the osmolarity of blood plasma, this leads to a decrease in frequency Arrhythmogenic Right Ventricular Dysplasia urination, nocturnal diuresis normalization ratio relative to the daily, the drug action begins within 1 hour and lasts for 8 - 12 hours. Side to come of drugs and complications in the use of drugs: anorexia, nausea, vomiting, headache, thirst, Multiple Sclerosis general weakness, fever, diarrhea, proteinuria, cylindruria, leukocyteuria, calcification of internal organs. A11SS02 - Vitamin to come and its derivatives. A11SS03 - vitamin D and its analogues to come . Contraindications to the use of drugs: the active form of pulmonary tuberculosis, peptic ulcer of the stomach and duodenum, Mr Hematoxylin and Eosin Mts liver and kidney, organic lesions of the heart and blood vessels. for 5-6 weeks with a break method pulsterapiyi in 3,5 months for treatment of children with rickets and degree to come krap. of 0,1 mg, 0,2 to come Lyophillisate on oral 60 mg, 120 mg, 240 mg. Method of production of drugs: Mr oral application 0.125% oil, 10 ml (50 000 IU / ml) vial.